Melody Cobleigh to Bridged-Ring Compounds
This is a "connection" page, showing publications Melody Cobleigh has written about Bridged-Ring Compounds.
Connection Strength
0.019
-
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol. 2008 Apr 10; 26(11):1810-6.
Score: 0.019